A nephrology-focused pharmaceutical company is seeking innovative drug discovery concepts and druggable targets specifically for genetic kidney diseases, with a focus on rare conditions. They are also interested in novel drug discovery platforms that can be utilized for genetic kidney disease research.
Approaches of Interest:
- Therapeutic targets for Alport Syndrome; submissions should focus on either (i) small molecules, peptides, and druggable targets that can modulate COL4A3, COL4A4, and COL4A5 gene function or (ii) therapeutics targets that are critical...